Effects of medium chain triglycerides supplementation on insulin sensitivity and beta cell function: A feasibility study

Abstract

ObjectiveMedium chain triglycerides (MCT) have unique metabolic properties which may improve insulin sensitivity (Si) and beta cell function but data in humans are limited. We conducted a 6-week clinical trial of MCT oil supplementation.Methods22 subjects without diabetes (8 males, 14 females, mean ± standard error age 39±2.9 years, baseline BMI 27.0±1.4 kg/m2) were counseled to maintain their body weight and physical activity (PA) during the trial. Dietary intake, PA data, body composition, and resting energy expenditure (REE) were obtained through dietary recall, international PA questionnaire, dual x-ray absorptiometry, and indirect calorimetry, respectively. MCT prescriptions were given based on REE and PA to replace part of dietary fat with 30 grams of MCT per 2000 kcal daily. Insulin-modified frequently sampled intravenous glucose tolerance tests were performed before and after MCT to measure changes in Si, acute insulin response (AIR), disposition index (DI), and glucose effectiveness (Sg).ResultsMCT were well tolerated and weight remained stable (mean change 0.3 kg, p = 0.39). Fasting REE, respiratory quotient, and body composition were stable during the intervention. There were no significant changes in mean fasting glucose, insulin, insulin resistance, fasting total ketones, Si, AIR, DI, Sg, leptin, fructosamine, and proinsulin. The mean change in Si was 0.5 10−4 min-1 per mU/L (95% CI: -1.4, 2.4), corresponding to a 12% increase from baseline, and the range was -4.7 to 12.9 10−4 min-1 per mU/L. Mean total adiponectin decreased significantly from 22925 ng/mL at baseline to 17598 ng/mL at final visit (p = 0.02). The baseline clinical and laboratory parameters were not significantly associated with the change in Si.DiscussionThere were a wide range of changes in the minimal model parameters of glucose and insulin metabolism in subjects following 6 weeks of MCT as an isocaloric substitution for part of usual dietary fat intake. Since this was a single-arm non-randomized study without a control group, it cannot be certain whether these changes were due to MCT so further randomized controlled trials are warranted.

Lipidomics reveals association of circulating lipids with body mass index and outcomes in IgA nephropathy patients

“…HexCer and GlcCer), correlate negatively with treatment outcome in patients with TCM treatment. In consistent with our findings, MCTs were demonstrated to be associated with a decrease in adiposity and inflammation ( Thomas et al, 2019 ). Meanwhile, deregulation of sphingolipid metabolism, particularly S1P signaling, which was shown to be modulated by the TCM therapy, has been implicated to participate in chronic and acute kidney injury.…”

Integrated Metabolomics and Proteomics Dynamics of Serum Samples Reveals Dietary Zeolite Clinoptilolite Supplementation Restores Energy Balance in High Yielding Dairy Cows

“…For example, the metabolic pathway of glycerol was found to be much closer to that of glucose, when compared with other glucose precursors, and hence it is used in dairy diets during calving [41]. In addition, valproic acid and caprylic acid were both reported as increasing insulin sensitivity and improving energy storage [42,43]; nevertheless, no such effect was observed in cis-1,2-Cyclohexanediol.…”

Zastosowanie Frakcji MCT Z Oleju Kokosowego W Żywieniu I Wpływ Na Zdrowie

“…Kolejnym potwierdzonym działaniem oleju MCT jest zdolność modulowania wrażliwości tkanek na insulinę oraz tolerancji glukozy w stanach przed cukrzycowych [50,55,61]. Badanie przeprowadzone przez Terada i wsp.…”